Air India has moved its booking office from the historic AI building to CR2 Mall in Nariman Point, Mumbai. This move follows the sale of the 23-storey building to the state government for Rs 1,600 ...

Despite the negativity, Chum remains unfazed and chooses to focus on positivity. "It’s okay. Sometimes people will like you, ...

The demand for high-end residential properties has witnessed a significant surge in the post-pandemic era. Evolving lifestyle ...

Dave Portnoy, the brash owner of Barstool Sports and President Trump supporter, said he was approached a job in the Trump ...

in Mumbai circuit, the Vicky Kaushal movie is only behind Allu Arjun's mega-hit Pushpa 2. Looking at the pace at which the historical drama is performing at the box office, the movie definitely ...

Merck Life Science has unveiled its Formulation & Technology Centre in Turbhe, Navi Mumbai. As a key part of Merck’s global R&D network, this next-generation facility will serve as a hub for industry ...

Work on the remaining 76-km stretch of the 701-km-long Nagpur-Mumbai Samruddhi Expressway, a key project initiated by Devendra Fadnavis, is now fully complete. The Maharashtra State Road ...

Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

On February 4, Merck released financial results for Q4 2024, which, as in previous quarters, once again beat analysts' expectations. This was driven by a strong performance by its oncology ...

Mer­ck said its “once-in-a-life­time” drug Keytru­da could be sub­ject to price re­duc­tions un­der the In­fla­tion Re­duc­tion Act, which would lead to a … ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

Ivonescimab, the new drug, was found in a trial conducted in China to have bested Keytruda, the blockbuster medication developed by Merck that has raked in more than $130 billion in sales for the ...